News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Nektar Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Business
EXCLUSIVE: Nektar Therapeutics, University of Texas MD Anderson Cancer Center Team Up on Phase 1/2 Trial of NKTR-214
June 2, 2015
·
5 min read
Policy
Nektar Therapeutics Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry
March 17, 2015
·
4 min read
Job Trends
Booming Nektar Therapeutics (CA) Grabs More Mission Bay Space; May Hire Another 150 Staffers
January 20, 2015
·
1 min read
Biotech Bay
Opioids Without Addiction, Nektar Therapeutics (CA) Reveals
September 4, 2013
·
1 min read
BioCapital
The Day In Review: Big M&A Activity In Biotech
September 21, 2006
·
1 min read
Biotech Beach
The Day In Review: Enzon Pharmaceuticals, Inc. Buys And Sells Drug Progams
July 27, 2006
·
1 min read
Biotech Beach
The Day In Review: Shire Pharmaceuticals Wins Elaprase Approval
July 24, 2006
·
1 min read
Biotech Beach
The Day In Review: Gilead Sciences (Foster City, CA) Pays $365 Million For Corus Pharma, Inc.
July 20, 2006
·
1 min read
Biotech Beach
The Day In Review: Diabetes News Rules
June 13, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Nektar Therapeutics Reports Second Quarter 2022 Financial Results
August 4, 2022
·
12 min read
Business
Nektar to Announce Financial Results for the Second Quarter 2022 on Thursday, August 4, 2022, After Close of U.S.-Based Financial Markets
July 26, 2022
·
1 min read
Biotech Bay
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
July 1, 2022
·
5 min read
Business
Nektar Therapeutics Reports First Quarter 2022 Financial Results
May 5, 2022
·
9 min read
Biotech Bay
Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook
April 25, 2022
·
9 min read
Drug Development
Nektar and Collaborators Present Preclinical Data on NKTR-255, a Novel IL-15 Receptor Agonist, in combination with CAR Cell Therapies at the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
April 23, 2022
·
8 min read
Biotech Bay
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors to Outline New Strategic Plan
April 22, 2022
·
1 min read
Biotech Bay
Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)
April 14, 2022
·
46 min read
Business
Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma
March 14, 2022
·
45 min read
Drug Development
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors Following Announcement of Update from Bristol-Myers Squibb and Nektar on the PIVOT-IO-001 Phase 3 Trial
March 14, 2022
·
1 min read
